Ketogenic Diet for Traumatic Brain Injury
NCT03982602 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 15
Last updated 2024-05-03
Summary
Traumatic Brain Injury is a major health concern in United States. There is a un-met need to develop new therapeutic options for faster neuron recovery without causing significant side effects. The role of ketones in neuronal recovery has been studied and has been found to be useful in decreasing size of contusion. The present study aims to study the safety and feasibility profile of ketogenic diet.
Conditions
- Traumatic Brain Injury
- Ketogenic Dieting
Interventions
- OTHER
-
Ketogenic diet
Subjects will be provided with the Ketogenic diet in the form of tube feeds once the decision is made to start the patient on diet.
Sponsors & Collaborators
-
University of Missouri-Columbia
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-07-04
- Primary Completion
- 2024-04-30
- Completion
- 2024-04-30
Countries
- United States
Study Locations
More Related Trials
-
The Effect of Intermittent Fasting on Acute Subconcussive Head Impacts
NCT05236127 ·Status: COMPLETED ·Phase: NA
-
The Effect of Creatine Monohydrate on Persistent Post-concussive Symptoms
NCT05562232 ·Status: RECRUITING ·Phase: NA
-
Neurocognitive Dysfunction After Anesthesia in Patients With Recent Concussion
NCT03952208 ·Status: COMPLETED ·Phase: NA
-
Creatine Monohydrate for Mild Traumatic Brain Injury: a Randomised Controlled Pilot Study
NCT06644131 ·Status: COMPLETED ·Phase: NA
-
Amino Acid Supplementation in Recovery From Traumatic Brain Injury
NCT01495871 ·Status: WITHDRAWN ·Phase: NA
-
The Anaesthetic Ketamine as Treatment for Patients With Severe Acute Brain Injury
NCT05095857 ·Status: RECRUITING ·Phase: PHASE4
-
Effects of Intravascular Administration of Mesenchymal Stromal Cells Derived from Wharton's Jelly of the Umbilical Cord on Systemic Immunomodulation and Neuroinflammation After Traumatic Brain Injury.
NCT06146062 ·Status: RECRUITING ·Phase: PHASE2
-
Protein Supplementation in Infants With Brain Injury
NCT01936246 ·Status: COMPLETED ·Phase: NA
-
Comparison Between Effect of Vitamin D Versus Dexmedetomidine in Patients with Head Trauma Using Interleukin 6
NCT06565338 ·Status: COMPLETED
-
Blood Flow Restriction Concussion
NCT03695042 ·Status: TERMINATED ·Phase: NA
-
Creatine Supplementation in Concussion Recovery
NCT06208813 ·Status: RECRUITING ·Phase: NA
-
Lactate Therapy After Traumatic Brain Injury
NCT01573507 ·Status: COMPLETED ·Phase: NA
-
Cerebral Autoregulation, Brain Perfusion, and Neurocognitive Outcomes After Traumatic Brain Injury
NCT06480838 ·Status: RECRUITING
-
Spreading Depolarization and Ketamine Suppression
NCT02501941 ·Status: COMPLETED ·Phase: PHASE1
-
Cerebral Autoregulation and Vasospasm in Patients With TBI
NCT02351518 ·Status: COMPLETED
-
Vitamin B12 vs B3 for Nerve Regeneration and Functional Recovery After Pediatric Traumatic Brain Injury
NCT05958277 ·Status: COMPLETED ·Phase: PHASE3
-
HEMOglobin Transfusion Threshold in Traumatic Brain Injury OptimizatioN: The HEMOTION Trial
NCT03260478 ·Status: COMPLETED ·Phase: NA
-
The Relationship Between Lipid Peroxidation Products From Traumatic Brain Injury and Secondary Coagulation Disorders
NCT04274777 ·Status: UNKNOWN
-
Outcomes Associated With Application of a Normothermia Protocol in Patients With Severe Neurological Insult and Fever
NCT00890604 ·Status: COMPLETED ·Phase: NA
-
Incidence/Magnitude-Haemorrhagic Progression-Cerebral Contusions and Identification (ID) of Safety Issues After Traumatic Brain Injury
NCT00124293 ·Status: COMPLETED
-
Imaging of Traumatic Brain Injury Metabolism Using Hyperpolarized Carbon-13 Pyruvate
NCT03502967 ·Status: ENROLLING_BY_INVITATION ·Phase: EARLY_PHASE1
-
Magnesium Sulfate For Brain Injury
NCT00004730 ·Status: COMPLETED ·Phase: PHASE3
-
Stellate Block Versus Nimodipine Infusion for Traumatic Brain Injury
NCT05182619 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Effects of Intranasal Nerve Growth Factor for Traumatic Brain Injury
NCT01212679 ·Status: COMPLETED ·Phase: PHASE2
-
Use of Cerebral Biomarkers in Minor Traumatic Brain Injury in the Emergency Unit
NCT06069674 ·Status: RECRUITING